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ABSTRACT 
 
Microbes frequently live within multicellular, solid surface-attached assemblages termed biofilms. These microbial 
communities have architectural features that contribute to population heterogeneity and consequently to emergent cell 
functions. Therefore, three-dimensional (3D) features of biofilm structure are important for understanding the 
physiology and ecology of these microbial systems. This paper details several protocols for scanning electron 
microscopy and confocal laser scanning microscopy (CLSM) of biofilms grown on polystyrene pegs in the Calgary 
Biofilm Device (CBD). Furthermore, a procedure is described for image processing of CLSM data stacks using amira™, 
a virtual reality tool, to create surface and/or volume rendered 3D visualizations of biofilm microorganisms. The 
combination of microscopy with microbial cultivation in the CBD – an apparatus that was designed for high-
throughput susceptibility testing – allows for structure-function analysis of biofilms under multivariate growth and 
exposure conditions. 
 
 
INTRODUCTION 
 
Life in a biofilm is part of the ecological cycle for the vast 
majority of bacteria and yeasts found in the environment 
and implicated in chronic disease (1, 2). Growth in a 
biofilm is a developmental process that is in some 
regards analogous to differentiation in tissues of 
multicellular organisms, and likewise involves cell-to-
cell signals that regulate growth and coordinate cell 
behaviour (3-5). Biofilm formation occurs when 
microorganisms stick to a surface and become 
permanently attached, eliciting a change in physiology. 
These microbes then grow and divide to form highly 
ordered, matrix encased assemblages, all under the 
control of biofilm specific genes (6). The structure and 
development of mature biofilms is correlated to 
emergent biological properties of the adherent microbial 
community, such as metabolic stratification (7), 
antimicrobial resistance (8, 9), active dispersal processes 
(10) and virulence (11). Biofilm architecture is further 
influenced by environmental conditions, such as nutrient 
status (12), heavy metals (J. J. Harrison, H. Ceri and R. J. 
Turner, unpublished data), material composition and 
roughness of the substratum (13), as well as 
hydrodynamic shear force (14). Therefore, laboratory 
systems for imaging microbial biofilms as well as 
computer algorithms for analyzing this data are valuable     
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research tools in microbiology. 
 
Our group has previously described the Calgary Biofilm 
Device (CBD) for high-throughput susceptibility testing 
of microbial biofilms to antibiotics (15), disinfectants and 
metals (16, 17). This system consists of a polystyrene lid 
with 96 downwards protruding pegs that can be fitted 
into a standard 96-well microtiter plate. Through the use 
of this method, one batch culture apparatus allows single 
or multiple species biofilms to be tested against an 8 × 12 
matrix of controlled variables. These variables may 
include growth medium formulations, exposure times, as 
well as antimicrobials at varying concentrations - alone 
or in combination. Here we report microscopy and image 
processing techniques to evaluate the biofilm community 
structures produced by bacteria and fungi cultivated in 
the CBD. The project to create these tools was 
undertaken with a single, specific aim: to provide a 
means to examine microbial biofilm structures under 
multivariate growth and/or exposure conditions. 
 
This study presents several protocols for use in scanning 
electron microscopy (SEM), confocal laser scanning 
microscopy (CLSM), and three-dimensional (3D) 
visualization of CBD biofilms. For the purpose of 
computer rendering, virtual reality (VR) technology 
(amira™) was used to dynamically visualize CLSM data. 
This process functions in a manner analogous to 3D 
reconstruction of organs or tissues from two-dimensional 
(2D) stacks of medical images. As illustrative examples, 
these various techniques were used to examine the 
biofilm structures produced by several strains of 
Escherichia coli,  Pseudomonas aeruginosa,  Pseudomonas 
chlororaphis,  Pseudomonas fluorescens,  Burkholderia 
cenocepacia,  Staphylococcus aureus and Candida tropicalis. 
The ability of the CBD to generate a large number of 
biofilm replicates was also used for the evaluation of a 
variety of fixing protocols and combinations of 
fluorescent stains. In this latter category, we describe the 
use of acridine orange, viability staining with Syto-9 and 
propidium iodide (components of the Live/Dead® 
bacterial cell viability kit), as well as the use of 
fluorophore-conjugated lectins for the staining of biofilm 
extracellular polysaccharides (EPS). 
 
To validate the CBD as a tool for studying biofilm 
organization, three proof-in-principle experiments were 
carried out. First, the biofilm structures of several 
bacterial strains were evaluated in rich and minimal 
media, and the images presented here show that bacteria 
and fungi adopted a diverse range of structural 
conformations that were dependent on strain genetics as 
well as growth conditions. Second, Live/Dead® staining 
was used to illustrate that dead cells were a frequent, 
albeit variable, component of biofilms. Last of all, the 
staining of extracellular polymers using fluorophore-
conjugated lectins was used to show that this component 
of the biofilm matrix was unevenly distributed 
throughout the surface-adherent communities. 
Collectively, these proof-in-principle experiments were 
designed to simultaneously illustrate important caveats 
in the interpretation of microscopy data but also to 
validate the CBD as a potential tool for the study of 
biofilm structure-function relationships. 
 
MATERIALS AND METHODS 
 
Strains, growth media and buffers 
 
All of the strains used in this study are summarized in 
Table 1. Bacterial and fungal strains were stored in 
Micobank™ vials at -70°C as described by the 
manufacturer (ProLab Diagnostics, Richmond Hill, ON, 
Canada). The following growth media were used to 
culture these microorganisms as indicated throughout 
this study: trypticase soy agar (TSA) and trypticase soy 
broth (TSB) (EMD Chemicals Inc., Gibbstown, NJ, USA); 
Miller Luria-Bertani broth (LB, EMD Chemicals Inc.) or 
LB that was amended with 1.5% w/v granulated agar 
(LBA); King’s Broth (KB) that was prepared as 
previously described (18) or KB that was amended with 
1.5% w/v agar (KBA); minimal salts vitamins pyruvate 
(MSVP) broth (19) and minimal salts dextrose (MSD) 
broth (20), which were also prepared as previously 
described. Lastly, MSD plus yeast extract and casamino 
acids (MSD-YC) broth was prepared by enriching MSD 
with 2.0 g L-1 yeast extract and 1.0 g L-1 casamino acids 
(Sigma-Aldrich, St. Louis, MO, USA). The incubation 
temperatures required for microbial cultures varied from 
strain to strain and are indicated in Table 1. All rinse 
steps were performed by using either 0.9% saline or 
phosphate buffered saline (PBS; pH 7.4, 8.0 g NaCl, 200 
mg KCl, 1.44 g Na2HPO4, and 240 mg KH2PO4 per liter 
of double distilled water, ddH2O).     
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Biofilm cultivation 
 
Bacterial biofilms were grown in the Calgary Biofilm 
Device (CBD) as previously described by Ceri et al. (15) 
as well as by the manufacturer (Innovotech, Edmonton, 
AB, Canada). This method is briefly summarized here 
a n d  i s  i l l u s t r a t e d  i n  F i g u r e  1  ( A  t o  D ) .  T o  b e g i n ,  t h e  
desired bacterial or fungal strain was streaked out twice 
on agar, and colonies were suspended into fresh broth to 
match the optical density of a 1.0 McFarland standard. 
For the bacterial strains, this corresponded to 
approximately 3.0 × 108 cfu ml-1; for C. tropicalis this was 
approximately 3.0 × 106 cfu ml-1 (as verified by viable cell 
counts, see below). The cultures matching the optical 
standard were then diluted 30-fold in the appropriate 
broth medium, which subsequently served as the 
inoculum for the CBDs. 
 
Fig. 1: An overview for using the CBD for the purpose of microscopy and 3D visualization of microbial biofilms. A. To begin, fresh subcultures of the 
microbial strain were grown on the appropriate agar medium. B. Using a cotton swab, colonies from a fresh second subculture were suspended in broth 
medium to match a 1.0 McFarland standard. This was diluted 30-fold in broth to create the inoculum for the CBD. C. The peg lid of the CBD was either 
inserted into a microtiter plate (containing 150 µL of inoculum in each well) or a corrugated trough (with 22 mL of inoculum inside). The inoculated 
devices were placed in a humidified incubator on a gyrorotary shaker or platform rocker, respectively. D. After cultivation, biofilms were rinsed with saline 
to remove loosely adherent cells. E. Pegs were removed from the CBD using pliers and the biofilms then were enumerated by viable cell counting. A 
second set of pegs was removed for examination by microscopy. There is an option to expose biofilms to an array of antimicrobial agents or other test 
conditions and then to remove a second set of pegs for microscopy. F. For SEM, pegs were first fixed and then dehydrated, which was carried out using 1 
of 2 protocols. G. The fixed samples were mounted on stubs using epoxy resin, dried, and then sputter coated with gold-palladium. H. The biofilms were 
then examined by SEM, and the resulting images were contrast enhanced. I. For CLSM, pegs were immersed in the appropriate stain and then placed in 2 
drops of 0.9% saline on a glass coverslip. J. Images of the biofilms were captured using CLSM, and the instrument software was used to generate 2D 
averages of image z-stacks. K. The z-stacks were imported into amira™ for advanced image processing and 3D visualization. 
 
There were two methods used to cultivate biofilms on 
the polystyrene pegs of the CBD: the first method 
involved the use of a corrugated trough (the MBEC™-
High Throughput assay) (15), the second utilized a 
microtiter plate (the MBEC™-Physiology and Genetics 
assay) (21). For the first format of this assay, 22 mL of the     
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inoculum was transferred into the trough and the peg lid 
was then fitted inside of this. The assembled CBD was 
then placed on a rocking table (Bellco Biotechnology, 
Vineland, NJ, USA) at ~3.5 rocks per minute in a 
humidified incubator. For the second method of biofilm 
cultivation, 150 µL of the inoculum was added to each 
well of a 96-well microtiter plate. The peg lid was then 
fitted inside of this and the assembled device was placed 
on a gyrorotary shaker at ~150 revolutions per minute 
(rpm) in a humidified incubator. The cultivation method 
used for each bacterial or fungal strain is indicated in 
Table 1, and the method used was chosen based on 
which approach gave the greatest biofilm cell density, 
with the stipulation that the growth was statistically 
equivalent between the different rows of pegs (data not 
shown). The evaluation and choice for the method of 
biofilm growth on the surface of the CBD pegs using 
these two different assay formats has been previously 
described (15, 17). Following the desired period of 
incubation, the biofilms were rinsed by inserting the peg 
lids into microtiter plates with 200 µL of either 0.9% 
saline or PBS in each well for 2 min. 
 
The polystyrene pegs of the CBD have a surface area of 
approximately 109 mm2 and bear an overall neutral 
electrostatic charge. The rounded “tip” of each peg 
extends approximately 3-4 mm into the growth medium. 
Corresponding to this, the “air-liquid-surface interface” 
occurs approximately 4-5 mm above the tip after the 
inoculated device is agitated on a rocking table or 
gyrorotatry shaker. Note that to facilitate the growth of 
C. tropicalis 99916 on the surface of the CBD, the pegs 
were coated with L-lysine as previously described (22). 
This was accomplished by immersing the pegs into a 
solution of 1.0% L-lysine for 1 h, then by drying the peg 
lids upside down in a laminar flow hood for 30 min prior 
to use. 
 
Table 1: Bacterial and fungal strains used in this study. 
Genus and species  Strain  Genotype or description  Growth medium1 
Temperature 
(°C)/Format2 
Source 
Burkholderia cenocepacia  K56-2 Environmental  isolate  MSD-YC/TSA 35/S  (38) 
Candida tropicalis  99916  Clinical isolate, Foothills Hospital, Calgary, AB  TSB/TSA  35/S  (22) 
Escherichia coli  CFT073  Urinary tract isolate, genome sequenced  TSB/TSA  37/S  (39) 
 JM109 
endA1⋅recA1⋅gyrA96⋅hsdR17(rk-mk-)⋅ supE44⋅ recA1 
Δ(lac-proAB); F’(traD36⋅proAB+⋅lacIq⋅lacZ⋅M15) 
LB(A) 35/R  (40) 
 TG1 
supE⋅thi⋅hsd5⋅Δ(lac-proAB); 
F’(traD36⋅proAB+⋅lacIq⋅lacZ⋅M15) 
LB(A), MSD  35/R  (41) 
 DSS640  TG1  derivative;  ∆tatABC; Knr LB(A),  MSD  35/R  (42) 
Pseudomonas aeruginosa  ATCC 15442 
Standard reference strain for biocide susceptibility 
testing 
LB(A) 35/S  ATCC 
 ATCC  27853 
Standard reference strain for antibiotic susceptibility 
testing 
LB(A), MSVP  35/R  ATCC 
  PA14  Clinical isolate, genome sequenced  TSB/TSA  35/S  (43) 
Pseudomonas chlororaphis  PcO6 Environmental  isolate  KB/KA  20/S  (44) 
Pseudomonas fluorescens  ATCC 13525  Environmental isolate  LB  27/S  ATCC 
Staphylococcus aureus  ATCC 29213 
Standard reference strain for antibiotic susceptibility 
testing 
LB 35/R  ATCC 
1Abbreviations for growth media: KB = King’s broth; KA = King’s agar; LB = Luria-Bertani broth; LBA = Luria-Bertani agar; MSD = minimal salts 
dextrose; MSD-YC = minimal salts dextrose enriched with yeast extract and casamino acids; MSVP = minimal salts vitamins pyruvate; TSA = tryptic 
soy agar; TSB = tryptic soy broth 
2Denotes the incubation temperature and CBD assay format used: R = rocking table for trough format; S = gyrorotary shaker for microtiter plate 
format 
 
Viable cell counting 
 
Viable cell counts were determined after biofilms had 
been rinsed (as described above). Sample pegs were 
broken from the lid of the CBD using a pair of flamed 
pliers, then inserted into 200 µL of 0.9% saline in the 
wells of microtitre plate (Fig. 1E). Biofilms were 
disrupted from the peg surface using an Aquasonic 
250HT ultrasonic cleaner (VWR International, 
Mississauga, ON, Canada) set at 60 Hz for 5 min. The     
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disrupted biofilm cells were serially diluted in either 
0.9% saline or PBS, and then plated onto the appropriate 
agar medium. Agar plates were incubated for up to 48 h 
at the temperatures summarized in Table 1 and then 
enumerated. Viable cell counts for planktonic cultures 
(ex. starting inocula) were similarly carried out by serial 
dilution in 0.9% saline or PBS, and then by plating onto 
agar as described for biofilm cells.  
 
Scanning electron microscopy (SEM) 
 
Pegs were broken from the lid of the CBD using pliers 
and then rinsed once with 0.9% saline to disrupt loosely 
adherent planktonic cells. Two approaches were used for 
fixing the biofilms. In the first approach, biofilms were 
fixed with 2.5% glutaraldehyde in 0.1 M cacodylate 
buffer (pH 7.2) at 4°C for 20 hours. Following this, pegs 
were washed with 0.1 M cacodylate buffer and then 
rinsed with ddH2O (for 10 min at each step). 
Subsequently, the pegs were dehydrated with 70% 
ethanol and then air dried for 72 h before mounting. An 
alternate approach was used to examine extracellular 
polymeric substance (EPS) production. In this case, the 
rinsed biofilms were fixed with 0.1 M cacodylate buffer 
(pH 7.2) at room temperature for 2 h, then air dried for 
120 h before mounting. SEM was performed using a 
Hitachi model 450 scanning electron microscope as 
previously described (23). SEM images were contrast and 
brightness enhanced using Adobe® Photoshop® 7.0 
(Adobe Systems Inc., San Jose, CA, USA). This process is 
summarized in Figure 1 (F to H). 
 
Confocal laser scanning microscopy (CLSM) 
 
Pegs were broken from the lid of the CBD using pliers (as 
described above) and then rinsed once with 0.9% saline 
to disrupt planktonic bacteria. Prior to examination by 
CLSM, biofilms were fluorescently stained with one of 
the four following treatments: 1) acridine orange (AO), 2) 
Syto-9 and propidium iodide (PI), 3) AO and 
tetramethylrhodamine isothiocyanate conjugated 
concanavalin A (TRITC-ConA), or 4) Syto-9 and 
tetramethylrhodamine isothiocyanate conjugated peanut 
agglutinin (TRITC-PNA). The mechanism and procedure 
for cell staining are briefly summarized for each of these 
fluorescent compounds, and the general process for 
staining biofilms on pegs is illustrated in Figure 1 (I to 
K). 
 
AO is a membrane permeant nucleic acid stain that 
intercalates dsDNA and binds to ssDNA as well as to 
ssRNA through dye-base stacking to give broad 
spectrum fluorescence when excited at 476 nm (24). This 
compound stains all cells in a biofilm, live or dead, and 
may also bind to nucleic acids that are present in the 
extracellular matrix. To stain biofilms, pegs were 
immersed in 0.1% w/v acridine orange (Sigma Chemical 
Co., St. Louis, MO, USA) in PBS for 5 min at room 
temperature. 
 
Syto-9 and PI are packaged together as part of the 
Live/Dead® BacLight™ Kit for bacterial cell viability 
staining (Molecular Probes, Burlington, ON, Canada). 
Syto-9 (488 nm excitation, green emission) is a freely 
diffusible, nucleic acid intercalator that labels all cells in 
the microbial population regardless of viability. The 
counterstain, PI (543 nm excitation, red emission), is a 
membrane impermeant DNA intercalator that only stains 
cells with compromised membrane integrity. In 
principle, live cells stain green and dead cells stain 
orange-red. This has been shown to correlate well with 
viable cell counts for calibrated suspensions of many 
bacteria as well as for C. albicans (25). Here, cell viability 
staining of bacteria and fungi was carried out by 
incubating biofilms concomitantly with Syto-9 (6.7 µM) 
and PI (40 µM) at 30°C for 30 min as previously 
described by Jin et al. (25). 
 
To stain the extracellular polysaccharides in the matrix of 
P. aeruginosa and C. tropicalis biofilms, pegs were 
i m m e r s e d  i n  2 0 0  µ g  m l - 1  T R I T C - C o n A  ( M o l e c u l a r  
Probes) and incubated at 30°C for 90 min. ConA is a 
lectin with high specificity for mannose sugars present in 
the cell walls and biofilm matrix of Candida spp. (25) as 
well as P. aeruginosa (26). These pegs were subsequently 
treated with AO as described above. 
 
In contrast, the extracellular polysaccharide component 
of B. cenocepacia biofilms was labeled by immersing pegs 
in 50 µg ml-1 TRITC-PNA and incubating at 30°C for 60 
min. Peanut lectin specifically binds to D-galactose, 
which occurs three times in the heptasaccharide 
repeating unit that makes up the exopolysaccharide 
cepacian (which is specific to Burkholderia cepacia complex 
bacteria) (27). To preserve structure and extracellular     
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biomass in the case of B. cenocepacia, biofilms were fixed 
with 5% glutaraldehyde for 1 h at room temperature 
prior to staining. These fixed biofilms were rinsed 5 
times with 0.9% saline before mounting for microscopy. 
 
In all cases, fluorescently labelled biofilms were placed in 
two drops of 0.9% saline on the surface of a glass 
coverslip. These pegs were examined using a Leica DM 
IRE2 spectral confocal and multiphoton microscope with 
a Leica TCS SP2 acoustic optical beam splitter (AOBS) 
(Leica Microsystems, Richmond Hill, ON, Canada). To 
minimize or eliminate artefacts associated with single 
and/or simultaneous dual wavelength excitation, all dual 
labelled samples were sequentially scanned, frame-by-
frame, first at 476 or 488 nm and then at 543 nm. 
Fluorescence emission was then sequentially collected in 
the green and red regions of the spectrum, respectively. 
Line averaging (×2) was used to capture images with 
reduced noise. A 63 × water immersion objective was 
used in all imaging experiments. Image capture, two-
dimensional (2D) projections of z-stacks (see below) and 
3D reconstructions were performed using Leica Confocal 
Software (LCS, Leica Microsystems).  
 
Three-dimensional (3D) visualization 
 
Three-dimensional (3D) visualization of CLSM data were 
created using amira™ 4.0 (Mercury Computer Systems 
Inc., Chelmsford, MS, USA). The principle and 
application of using this software to the analysis of 
biofilm structure are briefly summarized here. CLSM 
data consists of a set of two-dimensional (2D), cross-
sectional images in the x-y plane that is captured along a 
z-axis. Collectively, a set of x-y images through the z-axis 
is termed a z-stack. Here, each individual x-y image was 
a 1024 × 1024 pixel tagged image file format (TIFF) file 
that corresponded to a cross-section through the biofilm. 
Points in 2D and 3D data sets are termed pixels and 
voxels, respectively. For instance, the x-y images in the z-
stack are composed of pixels, whereas the same point in 
the 3D volume data set is a voxel. There were two 
different methods used to visualize the microbial 
biofilms. 
 
First, the method of surface rendering was used to create 
biofilm 3D visualizations; in this approach 3D surfaces 
were created to encase the biomass by interconnecting its 
boundary voxels. Therefore, biofilm visualizations 
created in this manner were a geometric representation 
of a surface (termed an isosurface) from a 3D volume 
data set. CLSM z-stacks were processed by re-sampling 
and segmenting the images according to a threshold that 
was selected according to a fluorescence intensity 
histogram of the TIFF files. In this manner, segmentation 
partitioned the images into background and biomass 
voxels and this was further user verified by manually 
comparing segmented biomass to its 2D original. 
 
An alternative method was to use volume rendering, 
whereby biomass was a direct 3D visualization of the 3D 
volume data set, without the use of thresholding 
segmentation. Briefly, this method, termed ray tracing or 
ray casting, was based on the amount of light (in terms of 
colour and opacity values) that every pixel in an image 
was emitting and absorbing. For every pixel in the image 
a ray was shot into the data volume, and at a 
predetermined number of locations along the ray path, 
the colour and opacity values were obtained by 
interpolation, subject to a predetermined range of light 
intensity. In other words, every pixel displayed in the 
image had a colour and opacity as displayed relative to 
the viewing plane of the user. In comparison to surface 
rendering, volume rendering was computationally 
intense as it required more processor time and special 
hardware. 
 
In both cases, 3D visualization using amira™ allowed for 
dynamic display of the biofilm, such that the 
visualization of biomass could be examined from any 
viewpoint. This allowed for the detection of 3D features 
in these biological systems that were not perceptible 
from static 2D CLSM image stacks or from wireframe 
isosurface rendering carried out using LCS. Animations 
produced using amira™ were edited for screen 
resolution using Quicktime 7.1 Pro (Apple Computers 
Inc., Cupertino, CA, USA). 
 
Statistical tests and data analysis 
 
Mann-Whitney U-tests of viable cell counts were 
performed using MINITAB® Release 14 (Minitab Inc., 
State College, PA, USA) to analyze log10-transformed 
raw data. Alternate hypotheses were tested at the 95% 
level of confidence. Mean and standard deviation 
calculations were performed using Microsoft® Excel XP 
(Microsoft Corporation, Redmond, WA, USA).      
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RESULTS AND DISCUSSION 
 
Biofilm growth in the CBD 
 
Within our research group, every time an assay has been 
performed using the CBD, 3 or 4 pegs have been 
removed from the lid and the number of cells growing 
on the surface determined by viable cell counting. We 
have pooled the cumulative data from all of the studies 
previously undertaken by our research group that have 
specifically used the CBD to examine the microbial 
strains summarized in Table 1. The mean viable cell 
counts and standard deviations (in units of log10 cfu 
peg-1) for these bacterial and fungal strains (under all of 
the test conditions examined in this paper) are 
summarized in Table 2. The studies used to compile this 
data are indicated (where applicable), and this meta-
analysis allowed the number of viable cells growing in 
CBD biofilms to be quantified based on 3 to 202 
replicates for each strain. The rationale for this approach 
was that analyzing the results from a group of studies 
allowed for a more accurate representation of the mean 
and variation of biofilm growth on the surface of the 
CBD pegs. 
 
Comparative SEM analysis of biofilm structure 
 
SEM examination of biofilms cultivated in the CBD 
revealed that different bacterial strains adopted various 
structural conformations that were distinct from the 
“stalk” and “mushroom cap” biofilms formed in flow 
cells by P. aeruginosa. For instance, P. chlororaphis PcO6 
formed thick cell layers with high cell density (Fig. 2A) 
whereas S. aureus ATCC 29213 adhered to the pegs in 
clumps of approximately 2 to 20 cells (Fig. 2B). In 
another example, E. coli JM109 formed uneven layers of 
single and multiseptate cells that were clustered into 
mounds (Fig. 2C). The formation of multiseptate cells, 
which were chains of cells that did not separate from one 
another as is normal during planktonic cell replication 
and division, is a commonly observed event for many 
biofilm bacteria (H. Ceri, unpublished data). 
 
As researchers have begun to dissect the molecular 
mechanisms of biofilm formation, the concepts of 
“good,” “poor,” and “hyper-” biofilm forming bacterial 
strains have emerged. This is particularly relevant with 
regards to engineered mutants from strain libraries 
designed to identify genes important for the biofilm 
lifestyle. For example, wild type P. aeruginosa is 
considered a good biofilm former under many growth 
conditions (Table 2, Fig. 2D and 2G). Strains of this 
microorganism bearing inactivating mutations in the 
two-component regulatory system GacA/GacS have been 
labeled poor biofilm formers (21, 28), whereas small 
colony variant (SCV) strains of this microorganism have 
been labeled hyper-biofilm formers (29). In the example 
here, an E. coli mutant lacking the twin-arginine 
translocase (tat), a strain that is considered a poor biofilm 
former (20, 30), was compared to its wild type parental 
strain using comparative SEM analysis. 
 
 
Fig. 2: SEM of bacterial biofilms grown in the CBD. For the sake of 
comparison, the biofilms were grown in either rich or minimal medium (as 
summarized in Table 1) and then fixed using 1 of 2 different protocols. 
These micrographs were chosen to illustrate that medium composition 
has an impact on the capacity of bacteria to form biofilms, which further 
varies between genus, species and strains. Moreover, the choice of fixing 
protocols influences how well microstructures may be preserved, which 
may impact on the interpretation of SEM data. 
 
When grown in rich medium and examined using a 
standard fixing protocol, biofilms of E. coli TG1 (wild 
type) and DSS640 (tatABC ) similarly produced surface-
adherent layers of cells that had little EPS, and similarly, 
were thickest near the air-liquid-surface interface (Fig. 2E 
and 2F). A previous study by our group has revealed 
that the mean number of viable cells in E. coli DSS640 
biofilms is significantly less than that of the isogenic, 
wild type strain TG1 (Table 2, by means of a two-
population Mann-Whitney U-test, p < 0.001) (20). It is 
important to note that this difference was not perceptible     
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from examination by SEM (Fig. 2). Therefore, a first 
caveat to comparative studies using this technique is that 
viable cell counts (with statistical analysis) are required 
to give meaning to microscopy (Table 2). 
 
A variable influencing biofilm formation in the CBD was 
the choice of growth medium. For instance, biofilms of E. 
coli TG1 and DSS640 had a cell density that was 8 and 79 
times greater in LB than it was in MSD, respectively. To 
provide another cross comparison, biofilms of E. coli TG1 
grown in MSD had a mean viable cell count that was 16 
times greater than biofilms of E. coli DSS640 grown in 
MSD. This was a statistically significant difference (Table 
2, by means of a Mann-Whitney U-test, p < 0.001) that 
was readily observable by SEM (Fig. 2H and 2I). 
Therefore, under conditions of nutrient restriction, E. coli 
DSS640 may be considered a poor biofilm former relative 
to the isogenic, wild type strain. It is interesting to 
contrast these results to those for biofilms of E. coli TG1 
and DSS640 grown in rich medium, which, using 
comparative SEM analysis both appeared to be good 
biofilm formers. A caveat that emerges from this data set 
is that growth conditions are an important consideration 
when evaluating biofilm formation, as a good biofilm 
former in one medium may be a poor biofilm former in 
another. 
 
A final feature of SEM that warrants attention is that 
samples must be fixed and dehydrated, which may 
introduce experimental artifacts that affect the 
observation and interpretation of biofilm structure. This 
was examined here by using two different protocols for 
fixing biofilm E. coli TG1 and DSS640 cells to the CBD 
pegs. The first (standard) protocol employed two rinse 
steps after incubation of biofilm pegs in a glutaraldehyde 
fixative, followed by ethanol dehydration (Fig. 2E and 
2F). The alternative protocol required extended air 
drying after the incubation of pegs in a glutaraldehyde 
fixative, but did not utilize rinse or ethanol dehydration 
steps (Fig. 2J to 2L). The alternative protocol preserved 
biofilm extracellular polymers and revealed a tight 
organization of biofilm cells in situ. Using this latter 
protocol, biofilms of E. coli TG1 and DSS640 biofilms 
appeared similar to those we have previously reported 
for hyper-biofilm forming SCV strains of P. aeruginosa 
PA14 (fixed with the standard protocol) (21). By 
comparison, the standard protocol removed much of the 
adherent biomass and exposed a portion of the 
underlying cells. In other words, the method of fixing 
biofilm cells to pegs may introduce artifacts that affect 
the judgment concerning the capacity of a particular 
microbe to form biofilms. Thus, this experiment 
emphasizes the importance of a consistent experimental 
approach to create valid comparisons in SEM analysis. In 
this case, E. coli DSS640 may be considered a poor 
biofilm former in minimal media, a good biofilm former 
in rich media, or mistaken for a hyper-biofilm former 
when treated with an alternative fixing protocol. 
Table 2: Meta-analysis of mean viable cell counts for microbial biofilms cultivated in the CBD. 
Genus and species  Strain  Growth medium1  Time (h) 
Viable cell count  
(log10 cfu peg-1) 
Replicates Reference(s) 
B. cenocepacia  K56-2  MSD-YC  72  6.6 ± 0.4  4  this study 
C. tropicalis  99916  TSB  48  4.3 ± 0.4  202  (22, unpublished data) 
      72  4.3 ± 0.3  3  this study 
E. coli  CFT073  TSB  24  5.9 ± 0.3  71  unpublished data 
  JM109  LB  24  6.2 ± 0.5  119  (16, 17, 45) 
  TG1  LB  24  7.0 ± 0.3*  84  (17, 20) 
    MSD  24  6.1 ± 0.6**  40 (20) 
  DSS640  LB  24  6.8 ± 0.5*  80  (20) 
    MSD  24  4.9 ± 0.7**  40  (20) 
P. aeruginosa  ATCC 15442  TSB  24  6.8 ± 0.5  181  unpublished data 
  ATCC 27853  LB  9.5  6.9 ± 0.8  55  (16, 46) 
    MSVP  22  6.1 ± 0.4  133  (46), this study 
  PA14  TSB  24  6.3 ± 0.2  12  (21), this study 
P. chlororaphis  PcO6  KB  24  7.3 ± 0.2  4 this  study 
P. fluorescens  ATCC 13525  LB  24  6.0 ± 0.8  99 unpublished  data 
S. aureus  ATCC 29213  LB  24  6.2 ± 0.9  76 (16,  47) 
1 Abbreviations for growth media are the same as those listed in Table 1. 
* These values are significantly different by means of a Mann-Whitney U-Test (p < 0.01) 
** These values are significantly different by means of a Mann-Whitney U-Test (p < 0.01)  
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Acridine orange staining of microbial biofilms 
 
A O  m a y  b e  u s e d  a s  a  f l uorescent biofilm biomass 
indicator as it stains cells as well as the nucleic acids that 
are a normal component of the extracellular matrix (31). 
Here, this technique was used in conjunction with CLSM 
to illustrate the variety of structural formations that may 
be adopted by biofilm bacteria grown in the CBD. In the 
following examples, CLSM z-stacks were processed 
using Leica Confocal Software (LCS), which was used to 
generate 2D average projections as well as 3D 
visualizations of biofilms using an isosurface rendering 
algorithm. Each experiment was performed in triplicate 
and a representative example of each is shown here. 
 
There are many limitations to the interpretations that 
may be drawn from viability staining of biofilms using 
Syto-9 and PI; however, here we will address the 
limitation of sampling. A single field of view in a 
microscope does not represent a random sample from 
the entire biofilm population on the peg. Systematic 
collection of fields of view is a possible (but impractical) 
solution to quantify population survival in the CBD, 
which is more simply done through viable cell counting. 
Therefore, Live/Dead staining of CBD biofilms (as 
described here) is qualitative, and the discussion of semi-
quantitative image analysis using this method is beyond 
the scope of this manuscript. 
 
Despite pragmatic limitations on sampling, this type of 
assay is highly useful for spatial localization of dead cells 
in CBD biofilms following many antimicrobial 
treatments (19, 22, 25) as well as for qualitative assays 
such as the one described here. We acknowledge that 
dead cells are also a normal component of late 
logarithmic and stationary phase planktonic cell 
suspensions cultured in the CBD (J. J. Harrison, H. Ceri 
and R. J. Turner, unpublished data), and thus part of this 
dead biomass may be incorporated into the biofilm 
during growth. Nonetheless, this reinforces the notion 
that control groups are of pivotal importance when using 
Syto-9 and PI to evaluate the efficacy of anti-biofilm 
treatments, as every growing biofilm population 
normally contains a portion of dead biomass. 
Staining of biofilm extracellular polysaccharides using 
fluorescent lectins 
 
A distinguishing feature of biofilms is an extracellular 
matrix that is composed of short and long chain 
oligonucleotides (32), species specific proteins (33) and 
polysaccharides (31), as well as the biochemical 
derivatives and monomeric units of these compounds 
(26, 34). A strategy that has been employed to visualize 
extracellular polymers relies upon fluorophore-
conjugated lectins (see Materials and methods). In this 
study, we used TRITC-ConA and TRITC-PNA in 
conjunction with AO and Syto-9, respectively, to stain 
the biofilm extracellular matrix and surface-attached cells 
of C. tropicalis 99916 (Fig. 5A to 5C) and B. cenocepacia 
K56-2 (Fig. 5D to 5F). Each experiment was performed in 
triplicate using the CBD and a representative example of 
each is shown here. 
 
 
Fig. 3: CLSM of AO stained bacterial biofilms grown in the CBD. The 
images on the left are 2D averages of image z-stacks, whereas the 
images on the right are isosurface rendered 3D visualizations of the 
same data set (prepared using Leica® Confocal Software). These data 
sets illustrate that mature biofilms may adopt a number of structures 
that are distinct from the archetypal “stalk and mushroom” 
microcolony structures that are well characterized for P. aeruginosa. 
Each panel represents a square surface area of approximately 238 × 
238 µm.     
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Correlative to previous reports, we observed that ConA 
highlighted C. tropicalis 99916 cell walls and stained EPS 
to a lesser extent (8, 22). An overlay of AO and ConA 
2D average images revealed that yeast cells were in 
physical contact with their neighbours, joined either by 
their cell walls or a thin layer of EPS (Fig. 5A). The 
distribution of the extracellular biomass was also 
uneven, a feature that was shared in common with P. 
aeruginosa PA14 biofilms stained in a similar fashion 
(Fig. 6, discussed below with regards to 3D 
visualization). An overlay of Syto-9 and TRITC-PNA 2D 
average images additionally showed that B. cenocepacia 
K56-2 biofilms were encased in a heterogeneously 
distributed layer of EPS (Fig. 5D). Collectively, these 
data suggest that the production of extracellular 
polymers occurs non-uniformly throughout microbial 
biofilms. 
 
 
Fig. 4: CLSM of Live/Dead® (Syto-9 and PI) stained microbial 
biofilms grown in the CBD. C e l l dea t h  is  a  n o r m a l pa r t  o f  bio f i l m 
development (the extent of which may vary) and therefore dead 
biomass constitutes a portion of every biofilm. Each panel represents 
a square surface area of approximately 238 × 238 µm. 
 
In the case of B. cenocepacia K56-2, biofilms were fixed 
using glutaraldehyde and rinsed several times 
following staining with TRITC-PNA. As discussed for 
SEM, any method used to preserve the biofilm may 
affect community structure and in particular, remove 
components of the EPS. Based on the data presented in 
Figure 2, it is likely that ethanol dehydration of samples 
for SEM is for the most part responsible for the removal 
of the EPS layer. The advantage of CLSM is that the 
samples remain in an aqueous environment and as such 
it is reasonable to expect that a larger portion of EPS is 
retained using this technique than with SEM. 
 
3D visualization of CLSM data 
 
Image processing and analysis methods are widely 
used in microbiological research to qualitatively and/or 
semi-quantitatively characterize microorganisms 
growing in biofilms. There are three open-source 
s o f t w a r e  p a c k a g e s  t h a t  h a v e  b e e n  a p p l i e d  t o  t h e  
examination of multiple channel CLSM data sets from 
biofilms: daime (35), PHLIP (36), and COMSTAT (37). 
Here we describe the use of amira™, a professional 
software package for 3D visualization of volume data 
sets that utilizes hardware accelerated OpenGL 3D 
graphics with texture mapping. This software package 
was used to examine two additional CLSM data sets 
that were part of the proof-in-principle experiments 
described in this manuscript. First, P. aeruginosa PA14 
biofilms were examined by staining samples with AO 
and TRITC-ConA (Fig. 6A to 6G). This was carried out 
with the specific aim of visualizing the heterogeneous 
distribution of extracellular polymers throughout the 
surface-attached community. Second, C. tropicalis 99916 
biofilms (grown for 72 h on a gyrorotary shaker) were 
stained with Syto-9 and PI (Fig. 6H to 6N). This 
visualization was performed to illustrate that dead cells 
were a prevalent component of these biofilm 
communities. With regards to biofilm cultivation in the 
CBD and fluorescent staining, each of these 
experiments was performed in triplicate and a 
representative example of each was visualized using 
computer graphics (CG), as shown in the data 
presented here. Furthermore, two computational 
methods were used to examine these biofilm CLSM 
data sets.     
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Fig. 5: TRITC-conjugated lectin staining of C. tropicalis and B. cenocepacia biofilms. A. An overlay image of a C. tropicalis biofilm that was stained with 
AO (green emission) and TRITC-ConA (red emission). B. AO staining of the section illustrated in panel A. C. TRITC-ConA staining of the section illustrated 
in panel A. D. An overlay image of a B. cenocepacia biofilm that was stained with Syto-9 and TRITC-PNA. E. Syto-9 staining of the section illustrated in 
panel D. F. TRITC-PNA staining of the section illustrated in panel D. Each panel represents a square surface area of approximately 238 × 238 µm. 
 
The first visualization method used was isosurface 
rendering, whereby biofilm biomass was illustrated as 
a hollow shell that corresponded to the interconnected 
b o u n d a r y  v o x e l s  o f  t h e  f l u o r e s c e n t ,  3 D  v o l u m e  d a t a  
set. This method required that CLSM z-stacks were 
segmented, a user refined step carried out to separate 
background noise from biomass voxels. The advantage 
of this method was fast computer time and real-time 
user manipulability of the models without the 
requirement of specialized hardware (ex. expanded 
computer memory and specialized graphics cards). 
Isosurface rendering of CLSM data for P. aeruginosa 
PA14 and C. tropicalis 99916 is illustrated in Figure 6 
(panels B to D and O for P. aeruginosa; panels I to K 
and Q for C. tropicalis) as well as Supplementary 
Videos 1 and 2, respectively. 
 
The second method used to visualize biofilms was 
volume rendering, whereby 3D visualizations were a 
direct representation of the 3D volume data set (see 
Materials and Methods). This method did not require 
the use of image segmentation to separate noise from 
the emitted fluorescence signals, thereby reducing 
user manipulation of the CLSM data sets. This method     
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required greater processor time as well as hardware 
acceleration. Volume rendering of CLSM data for P. 
aeruginosa PA14 and C. tropicalis 99916 is illustrated in 
Figure 6 (panels E to 6 and P for P. aerugionsa; panels L 
to N and R for C. tropicalis) as well as Supplementary 
Videos 3 and 4, respectively. 
 
In summary, 3D visualization was used to 
dynamically illustrate 3D volume data sets from CLSM 
of biofilms cultivated in the CBD. With regards to the 
underlying biology of microbial biofilms, these data 
illustrated two important points that were the focus of 
the proof-in-principle experiments carried out in this 
manuscript. First, biofilms cultivated in the CBD 
displayed heterogeneity in the production of 
extracellular polysaccharides. Second, CBD biofilms 
contained a significant proportion of dead cells 
amongst the population. In this example, C. tropicalis 
99916 biofilms grown for 72 h had a number of viable 
cells equivalent to those cultivated for 48 h (Table 2). 
However, the aged biofilms were thicker, contained 
multiple cell morphotypes, as well as a much greater 
portion of dead cells in the population (compare Fig. 
4B and 6H).  
 
Conclusions 
 
I n  t h i s  m a n u s c r i p t  w e  h a v e  d e s c r i b e d  t h e  u s e  o f  
microscopy and 3D visualization methods to 
qualitatively evaluate the structure of microbial 
biofilms cultivated in the CBD. A feature of this model 
system for microbial cultivation was the ability to 
examine up to 96 biofilms in one batch culture 
apparatus. Therefore, biofilm structure may be 
evaluated under multivariate conditions and/or 
concomitantly with antimicrobial susceptibility testing 
or other biological assays (Fig. 1). For example, certain 
pegs may be removed from the device for microscopy, 
whereas others may be used for determining starting 
biofilm viable cell counts, and others still may be used 
for susceptibility determinations. In this fashion, the 
methods in this manuscript may be used to perform 
structure-function analysis of microbial biofilms under 
a combinatorial matrix of test conditions. 
 
We acknowledge that an important constraint of 
biofilm growth in the CBD is complex fluid dynamic 
conditions. This must be considered when comparing 
data obtained from other experimental configurations 
(that feature controlled fluid dynamic conditions) to 
the data obtained from the CBD. 
 
With regards to comparative analysis by microscopy, 
an experimental approach must be taken where 
biofilms of different microbial strains are treated in an 
identical fashion. Considerations for setting up 
microscopy analysis included the fixing protocol, 
choice of growth medium, viable cell counting, cross-
talk between fluorophores, as well as the method of 
3D visualization. Additionally, growth does not 
evenly cover the surface of a CBD peg. For instance, 
growth is typically greatest near the air-liquid-surface 
interface; therefore examination of pegs should be 
made in a systematic way to reflect this. In summary, 
microscopy and 3D visualization are important tools 
for biofilm research, and correctly designed studies 
using the CBD may allow for structure-function 
analyses on a high-throughput scale. 
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Fig. 6: 3D visualization of microbial biofilms using amira®. A. A 2D average of an image z-stack for a P. aeruginosa PA14 biofilm stained with AO and 
TRITC-ConA. B and C. Isosurface rendering of the 3D volume data sets for AO and TRITC-ConA, respectively, extrapolated from the image z-stacks used to 
create the image in panel A. D. The merged, isosurface rendered 3D volume data set for AO and TRITC-ConA. E to G. Volume rendering corresponding to 
the data sets presented in panels B to D. H. A 2D average of an image z-stack for a C. tropicalis 99916 biofilm stained with the Live/Dead® cell viability 
kit. I and J. Isosurface rendering of the 3D volume data sets for Syto-9 and PI respectively, extrapolated from the image z-stacks used to create the image 
in panel H. K. The merged, isosurface rendered 3D volume data set for Syto-9 and PI. L to M. Volume rendering corresponding to the data sets presented 
in panels I to K. O and P. The oblique view of the P. aeruginosa PA14 biofilm pictured in panel A visualized using isosurface and volume rendering, 
respectively. Q and R. The oblique view of the C. tropicalis 99916 biofilm pictured in panel H visualized using isosurface and volume rendering, 
respectively. Each 2D image panel or 3D model represents a square surface area of approximately 238 × 238 µm. 
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SUPPLEMENTAL INFORMATION 
 
Supplementary videos of an AO and TRITC-ConA 
stained  P. aeruginosa PA14 biofilm visualized using 
isosurface and volume rendering (Supplementary Videos 
1 and 3, respectively) as well as a Live/Dead® stained C. 
tropicalis 99916 biofilm visualized using these two 
methods (Supplementary Videos 2 and 4, respectively) 
are available on the authors’ website 
(http://www.acs.ucalgary.ca/~turnerr/biofilm.htm). These 
videos may be viewed using Quicktime 7, which is 
available free of charge from Apple Computers Inc. on 
the World Wide Web 
(http://www.apple.com/quicktime/win.html). 
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PROTOCOLS
 
Protocol 1 – Cultivating biofilms in the Calgary Biofilm Device 
 
Reagents 
 
•  Sterile CBD peg lid with 96-well microtiter plate or corrugated trough 
•  Sterile 96-well microtiter plates 
•  Sterile cotton swabs 
•  Sterile 16 × 100 mm glass culture tubes 
•  Sterile physiological saline solution (ex. PBS, 0.9% NaCl) 
•  Sterile micropipette tips (2-200 µl), in racks of 96 
•  Sterile 1 ml and 25 ml pipettes 
•  Sterile 50 ml culture tubes 
•  Sterile reagent reservoirs 
•  Agar and broth growth media specific for the microorganism to be cultured 
 
Protocol 
 
Cultivation of biofilms in the CBD using a microtiter plate 
 
**The following protocol describes the cultivation of biofilms in 96-well microtiter plates. An amendment to this 
protocol must be made for using the trough format of the CBD. This is described at the end of this section. 
 
1.  If using a cryogenic stock (at -70°C), streak out a first sub-culture of the desired bacterial or fungal strain on an 
appropriate agar plate. Incubate at the optimum growth temperature of the microorganism for a suitable period of 
time. For many bacterial strains, the first sub-culture may be sealed to minimize evaporation and stored at 4°C for 
up to 14 days. 
2.  Check the first sub-culture for purity (ie. only a single colony morphology should be present on the plate). 
3.  From the first sub-culture or from a clinical isolate, streak out a second sub-culture on an appropriate agar plate. 
Incubate at the optimum growth temperature of the microorganism for an appropriate period of time. The second 
sub-culture should be used within 24 h starting from the time it was first removed from incubation. 
4.  Verify the purity of the second sub-culture. 
5.  Open a sterile 96-well microtiter plate. For each CBD used, fill 4 ‘columns’ of the microtiter plate from ‘rows’ A to 
F with 180 µl of a physiological saline solution. 
6.  Put 1.5 ml (plus 1.0 ml for each additional CBD being inoculated at the same time) of the desired broth growth 
medium into a sterile glass test tube. 
7.  Using a sterile cotton swab, collect the bacterial colonies on the surface of the second agar sub-culture. Cover the 
tip of the cotton swab with a thin layer of bacteria. 
8.  Dip the cotton swab into the broth to suspend the bacteria. The goal is to create a suspension that matches a 1.0 
McFarland standard (ie. 3.0 x 108 cfu ml-1). Be careful not to get clumps of bacteria in the solution. 
9.  Suspend more colonies, if necessary, to match the optical standard. 
10.  Put 29 ml of the appropriate broth growth medium (e.g. TSB) into a sterile 50 ml polypropylene or glass tube. To 
this, add 1.0 ml of the 1.0 McFarland standard bacterial suspension. This 30 fold dilution of the 1.0 McFarland 
standard (ie. 1.0 x 107 cfu ml-1) serves as the inoculum for the MBEC™ device. 
11.  Open the sterile package of CBD. Pour the inoculum into a reagent reservoir. Using the multichannel pipette, add 
150 µl of the inoculum to each well of the 96-well tissue culture plate packaged with the CBD. Place the peg lid     
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into the microtiter plate. Ensure that the orientation of the plate matches the orientation of the lid (i.e. peg A1 must 
be inserted into well A1 of the microtiter plate, otherwise the device will not fit together correctly). Label the 
device appropriately. 
 
**The volume of inoculum used in this step has been calibrated such that the biofilm covers a surface area that is 
immersed, entirely, by the volume of antimicrobials used in the challenge plate set up in Step 3 (below). Using a larger 
volume of inoculum may lead to biofilm formation high on the peg that physically escapes exposure in this challenge 
step. 
 
12.  Place the device on the gyrorotary shaker in a humidified incubator at the appropriate temperature. The shaker 
should be set to between 100 and 150 revolutions per minute (rpm). 
13.  Serially dilute (ten-fold) a sample of the inoculum (do 3 or 4 replicates). These are controls used to verify the 
starting cell number in the inoculum. 
14.  Spot plate the serial 10 fold dilutions of the inoculum from 10-6 to 10-1 on an appropriately labeled series of agar 
plates. Incubate the spot plates for an appropriate period of time and score for growth. 
 
Cultivation of biofilms in the CBD using a trough 
 
All of the steps for biofilm cultivation are identical to those described above, except for the following two steps, which 
replace steps 11 and 12 from the protocol above. 
 
1.  Open the sterile package of the CBD. Using a sterile pipette, add 22 ml of the inoculum to the trough packaged 
with the device. Place the CBD peg lid onto the trough. 
2.  Place the device on the rocking table in a humidified incubator at the appropriate temperature. The table should 
be set to between 3 and 5 rocks per minute. 
 
**It is critical that the angle of the rocking table is set to between 9° and 16° of inclination. This motion must be 
symmetrical. 
 
Protocol 2 – Coating the CBD pegs with L-lysine 
 
Reagents 
 
•  Sterile CBD peg lid with 96-well microtiter plate or corrugated trough 
•  Sterile 96-well microtiter plates 
•  Sterile 1% L-lysine solution 
•  Sterile micropipette tips (2-200 µl), in racks of 96 
 
1% L-lysine solution 
 
•  Add 1.0 g of L-lysine to 100 mL of ddH2O 
•  Sterile filter at 0.20 µm 
 
Protocol 
 
1.  Add 200 µL of 1.0% L-lysine solution to each well of a microtiter plate. 
2.  Remove the sterile CBD from its package and insert the peg lid into the microtiter plate containing the 1 % L-
lysine solution. Incubate for 1 hour at room temperature. 
3.  Remove the peg lid from the microtiter plate and place upside down in a laminar flow hood for 30 min to air dry.     
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4.  Use the peg lid to cultivate biofilms as described in Protocol 1.  
 
Protocol 3 – Standard protocol for fixing biofilms onto the CBD pegs for SEM 
 
**Compared to Protocol 4, this harsh fixing technique is more destructive to biofilms, but allows the cell structure and 
organization of the underlying bacteria to be examined. 
 
Reagents 
 
•  Phosphate buffered saline (PBS, pH 7.2) 
•  70% glutaraldehyde, EM grade 
•  cacodylate buffer (0.1 M) 
•  2.5% or 5% glutaraldehyde in cacodylate buffer (0.1M) 
•  0.9% saline 
•  96-well microtiter plate 
•  Micropipette tips (2-200 µl), in racks of 96 
 
Cacodylate buffer (0.1 M) 
 
•  16 g of sodium cacodylate in 1 L of double distilled (ddH2O) 
•  Adjust to pH 7.2 
 
**Wear gloves  
 
Glutaraldehyde (2.5% or 5%) 
 
•  To prepare a 2.5% solution, dissolve 2 ml of 70% glutaraldehyde in 52 ml of cacodylate buffer (0.1 M) 
•  To prepare a 5% solution, dissolve 2 ml of 70% glutaraldehyde into 26 ml of cacodylate buffer (0.1 M) 
 
**Wear gloves and use in a fume hood 
 
Protocol 
 
1.  Break pegs from the CBD using a pair of flamed pliers. 
2.  Rinse pegs in 0.9% saline for 2 min by placing the pegs into 200 µL of 0.9% saline in the wells of a 96-well 
microtiter plate. This disrupts loosely adherent planktonic bacteria from the peg surface. 
3.  Fix the pegs in by placing into 2.5% glutaraldhyde in 0.1 M cacodylic acid (pH 7.2). Pegs are placed in this solution 
at 4°C for 16 h. Alternatively, pegs may be placed into 2.5% glutaraldehyde at room temperature for 2 h. A 5% 
solution of glutaraldehyde may be substituted for the 2.5% solution. 
4.  Following this fixing step, wash the pegs once in cacodylate buffer (0.1 M) for approximately 10 min. 
5.  Wash the pegs once in ddH2O for approximately 10 min. 
6.  Dehydrate the pegs in 70% ethanol for 15 to 20 minutes. 
7.  Air dry for a minimum of 24 h. 
8.  Mount specimens for SEM. 
 
Protocol 4 - Alternative protocol for fixing biofilms onto the CBD pegs for SEM 
 
**C o m p a r e d  t o  P r o t o c o l  3 ,  t h i s  t e c h n i q u e  i s  r e l a t i v e l y  g e n t l e  a n d  c a n  b e  u s e d  t o  o b s e r v e  E P S  a n d  b i o f i l m  
ultrastructure, albeit dehydrated.     
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Reagents 
 
•  Phosphate buffered saline (PBS, pH 7.2) 
•  70% glutaraldehyde, EM grade 
•  cacodylate buffer (0.1 M) 
•  2.5% glutaraldehyde in cacodylate buffer (0.1M) 
•  0.9% saline 
•  96-well microtiter plate 
•  Micropipette tips (2-200 µl), in racks of 96 
 
Protocol 
 
1.  Prepare solutions of cacodylate buffer (0.1 M) and glutaraldehyde (2.5%) as described in Protocol 3 above. 
2.  Break pegs from the CBD using a pair of flamed pliers. 
3.  Rinse pegs in 0.9% saline for 2 min. This disrupts loosely adherent planktonic bacteria from the peg surface. 
4.  Fix the biofilms in glutaraldhyde (2.5%). Pegs are placed in this solution at room temperature for 2 h. 
5.  Air dry for at least 120 h. 
6.  Mount specimens for SEM. 
 
Protocol 5 - Fixing biofilms onto the CBD pegs for CLSM 
 
**This protocol is not compatible with fluorescent staining using the Live/Dead® kit for bacterial cell viability. 
 
Reagents 
 
•  Phosphate buffered saline (PBS, pH 7.2) 
•  5% glutaraldehyde in PBS 
•  0.9% saline 
•  96-well microtiter plate 
 
Protocol 
 
1.  Break pegs from the CBD using a pair of flamed pliers. 
2.  Rinse pegs in 0.9% saline for 1 min. This disrupts loosely-adherent planktonic bacteria. 
3.  Fix the pegs in 5% glutaraldhyde in PBS (pH 7.2). Pegs are placed in this solution at 30°C for 30 min to 1 h. 
4.  Rinse pegs in 0.9% saline for 1 min. 
5.  Stain pegs with the appropriate fluorphores and examine using the confocal laser scanning microscope as indicated 
in Protocol 6. 
 
Protocol 6 – Fluroescent staining and mounting of pegs for CSLM 
 
Reagents 
 
•  0.9% saline 
•  96-well microtiter plate 
•  Micropipette tips (2-200 µL), in racks of 96 
 
Protocol     
 
 
Harrison et al. - The use of microscopy and three-dimensional visualization to evaluate the structure of microbial biofilms cultivated in the Calgary Biofilm 
Device 
www.biologicalprocedures.com 
214
 
**There is an option here to fix the biofilms using glutaraldehyde. To do this, perform Protocol 5 instead of steps 1 and 
2 below. 
 
1.  Break pegs from the CBD using a pair of flamed pliers. 
2.  Rinse the biofilms by immersing the pegs into 200 µL of 0.9% saline in the wells of a microtiter plate. Incubate for 
1 min at room temperature. 
3.  Prepare the fluorescent stains as indicated in Table 3, or alternatively use the directions supplied by the 
manufacturer. Place 200 µL of the fluorescent stain in the required number of wells in the microtiter plate. 
4.  Using a pair of tweezers, transfer the pegs from the rinse into the fluorescent staining solution. Wrap the 
microtiter plate with tin foil and incubate for the required period of time. 
5.  If required as part of a second step, transfer the pegs into the required counterstain, wrap in tin foil, and then 
incubate for the required period of time. 
6.  Using a wax pencil, draw a circle on the surface of a 10 × 30 mm glass coverslip. With an eyedropper, put two 
drops of 0.9% saline in the middle of this circle. 
7.  **Do not use PBS for microscopy, as it may interfere with the fluorescence of some stains. 
8.  Use the tweezers to transfer the desired peg in to the saline on the glass coverslip. 
9.  Examine the biofilms using the confocal microscope as required by the system manufacturer. 
 
Protocol 7 – amira™ for 3D visualisation of biofilms 
 
**See the manufacturer’s website for minimum hardware requirements (Mercury Computer Products, 
http://www.tgs.com) .  T h i r t y - d a y  t r i a l  v e r s i o n  s o f t w a r e  i s  a l s o  a v a i l a b l e  f r e e  o f  c h a r g e  f r o m  t h e  c o m p a n y  a t  t h i s  
website. 
 
Protocol 
 
Importing CLSM image data 
 
1.  Execute the software Amira 4.0 from a workstation. 
2.  Choose the Load command from the File menu to make the file dialog box to appear 
3.  Navigate to the location of the image files that were in the “tiff” format and select all of them by clicking the first 
file and shift clicking the last one. 
4.  Click Load in the file dialog box to load all the images. 
5.  The Image Read Parameter dialog appears that prompts you for entering the physical dimension of the bounding 
box or alternatively, the size of the voxel. Default values were used for the current study. 
6.  Click OK to continue. 
7.  An icon in green representing the loaded images appears in the object pool under the menu bar. Right click on the 
icon to popup a submenu. Select Compute from the submenu to open a list of commands. Choose Resample from 
the list to generate a new icon in the object pool called Resample in red. 
8.  Select the Resample icon and edit its ports in the working area below the object pool. For a coarser resolution, 
change the Resolution port from x=1024, y=1024 into x=256, y=256. 
9.  Press the Apply button to execute the resampling process. 
10.  After the resampling process is complete, a new icon in green representing the resampled images appears in the 
object pool. 
11.  Right click on this new icon to popup a submenu and select BoundingBox to display a bounding box. 
 
Isosurface rendering 
     
 
 
Harrison et al. - The use of microscopy and three-dimensional visualization to evaluate the structure of microbial biofilms cultivated in the Calgary Biofilm 
Device 
www.biologicalprocedures.com 
215
12.  Right click on the icon of the resampled images to popup a submenu. Select Display from the submenu to open a 
list of commands. Choose IsoSurface from the list to generate a new icon in the object pool called IsoSurface in 
yellow. 
13.  Select the IsoSurface icon and edit its ports in the working area. Select the desired color and transparency from the 
Colormap port and adjust the value in the Threshold port to segment the resampled images. For semi-transparent 
display of IsoSurface, the Draw Style port needs to be set to transparent. 
14.  Press the Apply button to generate the 3D surfaces of the segmented images in the Viewer window. 
15.  Right click on the icon of the resampled images to popup a submenu. Select OrthoSlice from the submenu to 
generate a new icon in the object pool called OrthoSlice in orange and to overlay the original CLSM images to the 
3D surfaces in the Viewer window. 
16.  Select the IsoSurface icon to ensure its ports visible in the working area. Adjust the value in the Threshold port and 
press Apply button to update the new value. Repeat the process so that the 3D surfaces of the segmented images 
overlay exactly to the biomass in the original CLSM images.  
17.  Repeat from step 2 to step 11 and from step 12 to step 16 to add a new stack of CLSM images for isosurface 
rendering. 
 
Volume rendering 
 
18.  Right click on the icon of the resampled images to popup a submenu. Select Display from the submenu to open a 
list of commands. Choose Voltex from the list to generate a new icon in the object pool called Voltex in yellow. 
19.  Select the Voltex icon and edit its ports in the working area. Select the desired color and transparency from the 
Colormap port. 
20.  Press the Apply button to generate the 3D volume rendering of the resampled images in the Viewer window. 
21.  Repeat from step 2 to step 11 and from step 18 to step 20 to add a new stack of CLSM images for volume 
rendering. 
 
Table 3: Fluorescent stains for CLSM of microbial biofilms cultivated in the CBD (as described in this manuscript). 
Excitiation (nm) 
Collected emission 
(nm) 
Incubation time 
(min)  Stain 1a Stain  2a 
λ1  λ2  λ1  λ2  Stain 1  Stain 2 
AO (0.1% in PBS)  n/a  476  n/a  505 – 535  n/a  5  n/a 
TRITC-ConA (200 µg ml-1)  AO (0.1% in PBS)  543  476  555 – 615  505 – 535  60  5 
Syto-9b (6.7 µM)  PIb (40 µM)  488  543  510 – 540  610 – 670  30 (concomitant) 
TRITC-PNA (50 µg ml-1) Syto-9b (6.7 µM)  543  488  555 – 615  510 – 540  60  5 
aAbbreviations for fluorescent stains: AO = acridine orange; PI = propidium iodide; TRTIC-ConA = tetramethylrhodamine isothiocyanate conjugated 
concanavalin A; TRITC-PNA = tetramethylrhodamine isothiocyanate conjugated peanut agglutinin. 
bSyto-9 and PI were diluted 500-fold from the stock solutions provided by the manufacturer (Molecular Probes). 
n/a denotes an item that is not applicable. 
 
 